ASOs

Ionis Pharmaceuticals, a leader in RNA-targeted therapeutics, debuted as a top employer in *Science* magazine’s survey, ranking second. The company excelled in innovation, values alignment, employee loyalty, and respect. This recognition coincides with Ionis’ progress in RNA therapeutics, developing antisense oligonucleotides for diseases like spinal muscular atrophy. CEO Brett Monia credits the company’s success to its people and culture, while Eric Swayze emphasizes their patient-centric approach. Ionis faces increasing competition in the RNA therapy market but aims to maintain its leadership through continued innovation and talent retention.